Introduction
The tumor suppressor gene p53 is one of the best studied genes in human cancer research. In normal cells, p53 plays a pivotal role in regulating the cell cycle and in preventing neoplastic transformation (May and May, 1999; Burns and El-Deiry, 1999) . The p53 protein functions as a sequence-speci®c transcription factor that promotes expression of genes involved in cell cycle arrest, DNA editing and repair or DNA damageinduced apoptosis (Kaelin, 1999) . The intense interest in this gene results from its high frequency of mutation in human cancers (de Fromentel et al., 1992; May and May, 1999) . Mutations in human p53 [Homo sapiens p53 (Hsp53)] have been found in more than 50% of human cancers and are especially numerous in colorectal, lung and breast cancers and leukemias (Greenblatt et al., 1994) . Alternatively, abnormal p53 activity may result from dierential expression and degradation (Shieh et al., 1997) and phosphorylation and acetylation (Burns and El-Diery, 1999) . In some cancers, exclusion from the nucleus blocks p53-mediated inhibition of cellular proliferation (Moll et al., 1992 (Moll et al., , 1996 Lu et al., 2000) .
For more than 20 years, p53 was thought to be a unique gene in vertebrate genomes. Recently, however, two additional members of this expanding gene family were found in humans (Kaghad et al., 1997; Schmale and Bamberger, 1997; Osada et al., 1998; Senoo et al., 1998; Trink et al., 1998; Yang et al., 1998) . Human p63 (Hsp63) and p73 (Hsp73) genes encode proteins that share signi®cant amino acid identity with p53 (Levrero et al., 1999) . Both Hsp63 and Hsp73 have multiple splice variants that produce proteins with diering functions dependent upon the particular tissue type in which they are found (Marin and Kaelin, 2000) . The a splice variants of Hsp63 and Hsp73 proteins possess a variable C-terminal extension beyond the core sequence (Kaghad et al., 1997; Schmale and Bamburger, 1997) . These splice variants have reduced functional similarity to p53 and contain a conserved sterile alpha motif (SAM domain) that interacts with proteins involved in signal transduction and transcriptional repression (Jost et al., 1997; Kaghad et al., 1997; De Laurenzi et al., 1998; Yang et al., 1998; Thanos and Bowie, 1999) .
While p53 family members exist throughout the mammals, homologues for p73 in other vertebrates have only been reported for Barbus barbus (a cyprinid ®sh: Accession #AF043641; Bhaskaran et al., 2000) . In the invertebrates, a p73-like gene has been identi®ed for Loligo forbesi (squid; Accession #U43595), a p53-like gene has been identi®ed and its role in apoptosis characterized for Drosophila melanogaster (fruit¯y; Brodsky et al., 2000; Ollmann et al., 2000; Steller, 2000) and previously, partial p53 sequences were identi®ed for M. arenaria (Barker et al., 1997; Accession #U45237 and #U45238) . Here we report the full-length p53 and p73 cDNA homologues for M. arenaria (Accession #AF253323 and #AF253324, respectively).
M. arenaria provides a non-traditional model for studies of p53 and p73 protein structure and function in a naturally-occurring leukemia. Bivalve mollusks have an open circulatory system in which a tubular heart weakly pumps hemolymph to major vessels and then to endothelium-lined sinuses that permeate the gonad, gills, foot, mantle, digestive gland and other organs. In normal clams, agranular and granular hemocytes have a broad range of functions, including defense against pathogens, digestion and excretion (Auret, 1988) . The origin of these hemocytes remains unknown (Cheng, 1981 and references therein). M. arenaria develops a fatal leukemia at high incidence (up to 60%) in natural populations along the northeastern coastal US (Reinisch et al., 1984; Elston et al., 1992) . Morphologically, diseased hemocytes resemble human Burkitt's lymphoma cells (Baine, 1999; Walker CW, unpublished observations) .
In this study, we present cDNA sequences for the clam homologues of the Hsp53 and Hsp73 genes. The highly conserved structure of the clam genes relative to the corresponding human genes suggests that they may have similar functions. Protein expression patterns for both homologues, M. arenaria p53 (Map53) and p73 (Map73) are compared for normal and leukemic clam tissues. Only Map73 is dierentially expressed in this clam disease background. Both Map53 and Map73 proteins are sequestered in the cytoplasm and thus absent from the nuclei of leukemic clam hemocytes.
Results
Comparison of p53 and p73 from M. arenaria with other p53 homologues
The full-length cDNAs for Map53 and Map73 were identi®ed from normal gill tissue. The cDNA for Map53 is 2537 base pairs (bp) long with an open reading frame (ORF) of 1305 bp; Map73 is 2451 bp long with an ORF of 1839 bp (Figure 1 ). There are two possible start codons (nucleotides (nt) 79 ± 81 and 103 ± 105) that initiate ORFs. Map53 encodes a protein of 435 amino acids (relative to the second ATG) with a calculated molecular mass of 52.8 kDa; Map73 encodes a protein of 613 amino acids with a calculated molecular mass of 74.8 kDa. The core sequence for both Map53 and Map73 is essentially identical through amino acid 405, after which the sequences diverge (Figures 1 and 2 ). Map53 has a short C-terminal extension, while Map73 contains an elongated Cterminal extension including a SAM domain. Map53 diers signi®cantly in structure from D. melanogaster p53. Map73 is more similar to squid (L. forbesi) Sqp73 than to either Hsp53 or Hsp73 (Figure 2 ).
Transcriptional activation domain (TAD) In Hsp53, amino acids 12 ± 23 constitute a TAD that interacts with the basal transcriptional machinery to promote expression of genes related to: (a) negative regulation of p53 (Honda et al., 1997) ; (b) DNA editing and repair (Tanaka et al., 2000) and (c) apoptosis (Miyashita et al., 1994; O'Connor et al., 1997; Avramis et al., 1998; Tanaka et al., 2000) . The TAD of Map53/73 is 67% identical to that of Hsp53, while only 33 and 42% identical to Hsp63 and Hsp73, respectively. Amino acid residues F19, W23 and L26 Figure 1 Nucleotide and predicted amino acid sequence including 5' and 3' untranslated regions (UTRs) for Map53 and Map73. Core sequence (nucleotide (nt) 1 ± 1317) for Map53 and Map73 is nearly identical. Five nt dierences were identi®ed in the core sequence between Map53 and Map73 with two resulting in amino acid changes (nt 131 and 323=C, both amino acids change to P; nt 330=T, 768 and 824=C, no amino acid changes; indicated by italics). PolyA(+) tail (not shown) immediately follows end of 3' UTR for both Map53 and Map73. Two possible start codons (ATG) are shown in bold, and cytoplasmic and nuclear polyadenylation signals are underlined; stop codons are indicated by asterisks (*). Numbers correspond to nt sequence present in Hsp53 and essential for binding, MDM2 (HDM2 in humans) are conserved in the clam homologues (Figure 2 ; Kussie et al., 1996; Dobbelstein et al., 1998) .
DNA-binding domain (DBD)
The DBD in Map53/73 is localized between amino acid residues 102 and 292 and contains four highly conserved DNA-binding motifs (II-V; Figure 2 of amino acid sequences for p53 and p73 homologues from M. arenaria (Map53 and Map73) with human p53 (Hsp53), p63a (Hsp63a) and p73a (Hsp73a), the p73 homologue from L. forbesi (Sqp73) and the p53 homologue from D. melanogaster (Dmp53). Abbreviations: PxxP, proline rich domain; NLS I & II, nuclear localization domains; NES, nuclear export domain, SAM, sterile alpha motif; DNA binding domains, DBDs I ± V; *, putative conserved phosphorylation sites; #, conserved hydrophobic residues which in Hsp53 interact with MDM2; }, residues in Hsp53 that bind DNA;¨, Hsp53 mutational hot-spots; Zn, residues involved in zinc binding closely related to Hsp53 and the remaining DBDs more closely related to Hsp73.
Other conserved regions Following the TAD in Hsp53 is a proline rich domain (amino acids 63 and 97) containing ®ve PXXP motifs that are involved in apoptosis and may bind SH3-domain containing proteins (Walker and Levine, 1996; Venot et al., 1998) . In Map53/73, two PXXP motifs are present towards the C-terminal end of the corresponding proline rich domain; one is conserved with Hsp53 and the other is not conserved (Figure 2 ).
Map53/73 has a bipartite nuclear localization signal (NLS), while the NLS of Hsp53 is tripartite (Dang and Lee, 1989; Shaulsky et al., 1991; Liang and Clarke, 1999) . NLS I of M. arenaria is conserved with all p53/ 63/73 homologues in vertebrates and invertebrates while NLS II is weakly similar to the NLS of vertebrate p53 ( Figure 2 ). The Map53/73 NLS I precedes the tetramerization domain and also contains the lysine residue that is acetylated in Hsp53 by PCAF, which enhances p53 sequence speci®c DNA binding (Nishimori et al., 2000; Liu et al., 2000) .
Hsp53 functions as a tetramer, with residues 323 ± 356 required for tetramerization ( Figure 2) . Overall, the tetramerization domain of Map53/73 is 59% similar to Hsp53 and 81% similar to Hsp73. A nuclear export signal exists within the tetramerization domain. In Hsp53, the nuclear export signal is a leucine rich sequence, MFXXLXXXLXL (Stommel et al., 1999) ; a similar sequence (MLXXIXXXLXI) is also present in the tetramerization domain of Map53/73.
Map53 has a unique short C-terminal region that is not conserved relative to Hsp53 and only slightly conserved relative to Hsp63 and Hsp73. Map73 has a much longer C-terminal region than Map53 and contains a SAM domain that is greater than 50% conserved with those of Hsp63 and Hsp73.
Expression of p53 and p73 in normal and leukemic clams
Six clam tissues (gill, gonad, digestive gland, mantle, adductor muscle and hemocytes) were examined by Western blot analysis for expression of Map53 and Map73. Map53 was expressed at higher levels than Map73 in all tissues examined with the exception of the mantle where Map73 levels were relatively higher than Map53 (Figure 3 ). Map73 was not detected in normal clam hemocytes and may be present at very low levels in adductor muscle ( Figure 3 ). Comparison of Map53 and Map73 expression patterns between normal and leukemic clams showed that Map73 expression was elevated in both adductor muscle and hemocytes of leukemic clams (Figure 3 ). Map53 and Map73 were expressed at similar levels in leukemic clam hemocytes. Coomassie stained gels con®rmed that there was no detectable dierence in protein loading (data not shown). The unidenti®ed band (*70 kDa) detected in adductor muscle and hemocytes was inconsistently observed in dierent tissues in both normal and leukemic clams (Figure 3 ). Western blot analysis of in vitro expressed Map53 and Map73 proteins con®rms that the Map53/73 antibody recognizes both proteins ( Figure 3 ).
Subcellular localization of Map53/73
In normal clam hemocytes, immunocytochemistry using the Map53/73 antibody demonstrated that Map53 protein is predominantly present within the nucleus (Figure 4a ). In leukemic hemocytes, Map53 and Map73 were exclusively present within the cytoplasm and absent from the nucleus ( Figure 4b ). As a positive control, the Map53/73 polyclonal antibody recognized human proteins where they are normally present within most nuclei of patient-derived, human monocytic leukemia cells (AML-M5; Figure 4c ). (Figure 5a) . A striking similarity exists between clam leukemia and human Burkitt's lymphoma cells. Within the cytoplasm of these cancer cells which are derived from radically dierent sources (mollusk and mammal), there are numerous vacuoles (5 ± 15/cell) that stain intensely with oil red O. In humans, these vacuoles are diagnostic features for Burkitt's lymphoma (Grogan et al., 1982; Baine, 1999) (Figure 5b,c) . For comparison, monocytic leukemia cells from an AML-M5 patient were also stained with oil red O; oil red O staining vacuoles are absent from these cells (Figure 5d ).
Cytospins of clam and human leukemia cells

Discussion
To our knowledge, this study provides the ®rst fulllength cDNA sequences for both p53 and p73 and the only existing data on the expression and subcellular localization of the corresponding proteins for any nonvertebrate organism. The highly conserved structural domains that de®ne the p53 gene family members in humans are present in Map53 and Map73 suggesting that their functional roles may also be conserved in clams. Dierential patterns of expression for Map53 and Map73 are also documented in this naturally occurring, non-mammalian cancer. This disease in the softshell clam has morphological similarity to human diseases like Burkitt's lymphoma (Baine, 1999; Walker, unpublished observations) . Furthermore, elevated expression of the Map73 protein and absence of Map53/ 73 proteins from the nuclei of leukemic clam hemocytes, suggest a biological role for Map53 and Map73 in this clam disease, which appears similar in many respects to several human cancers.
Structural aspects of Map53 and Map73: comparison to Hsp53
In Map53/73 there are two possible start codons (ATG), both of which initiate an ORF (Figure 1 ). With the exception of some protooncogenes and growth-control genes,`non-functional' initiating codons are rare in vertebrates, but appear to be more common in D. melanogaster (Kozak, 1987 (Kozak, , 1989 . Based on the conserved Kozak sequence (Kozak, 1989) and alignment with other p53 homologues, we predict that the second ATG is the most likely start site for Map53/73 translation. However, if translation begins at the ®rst ATG, then an N-terminal tag may result on Map 53/73 that is similar to Hsp63 but not found in other Hsp53/p73s. In the core sequence of Map53 and Map73, ®ve nucleotide dierences were identi®ed that likely re¯ect polymorphisms. It is possible that the dierences may have resulted from polymerase errors in the PCR or sequencing reactions, although clones were sequenced in both directions at least once using a high ®delity polymerase in the PCR (see Materials and methods).
Signi®cant sequence identity to the Hsp53 TAD suggests that Map53/73 may be responsible for the transactivation of genes involved in: (a) negative regulation of p53 (Honda et al., 1997) ; (b) DNA editing and repair (Tanaka et al., 2000) and (c) apoptosis (Miyashita et al., 1994; O'Connor et al., 1997; Avramis et al., 1998; Tanaka et al., 2000) . Of particular interest is MDM2, a ring ®nger, E3 ubiquitin-protein ligase that blocks transcriptional activity of Hsp53 in addition to targeting it for proteolysis. The binding site for MDM2 (QETFSDLWKLLP) is contained within the TAD of Hsp53 and has the conserved motif xxxFxxxWxxLx. Amino acids F, W and L are important in stabilization of hydrophobic interactions between MDM2 and Hsp53 (Kussie et al., 1996) . The binding site for MDM2 in Map53/73 is 58% identical to Hsp53. Residues 16 ± 27 (QETFEYLWHTLE) in Map53/73 include the critical amino acids F, W and L. Potentially important regulatory phosphorylation sites are also present within the TAD of Map53/73, e.g. S15 (Hsp53 S15) and T18 (Hsp53 T18). In humans, phosphorylation of S15 is sucient to block MDM2 binding and leads to accumulation of p53 protein (Banin et al., 1998; Canman et al., 1998) . Hsp73 and Hsp63 also contain the MDM2 binding motif with 42 and 33% identity to Hsp53, respectively. Although Hsp73 can bind MDM2, it is not targeted for degradation by MDM2 (Balint et al., 1999; Zeng et al., 1999; Momand et al., 2000) . The MDM2 binding sites in Map53 and Map73 are identical to each other and more similar to the same site in Hsp53 than either Hsp63 or Hsp73, suggesting that both clam proteins may be negatively regulated and tagged for destruction by an MDM2 homologue. In order to test this hypothesis, studies are underway to identify an MDM2 homologue in M. arenaria.
The DBDs are highly conserved in vertebrate p53 family members. The DBDs of Hsp53 contain 80 ± 90% of the known mutations that have been described in a wide variety of human cancers (Cho et al., 1994; Greenblatt et al., 1994) . Eight amino acid residues that are most frequently mutated in Hsp53 (V173, R175, C243, G245, R248, R249, V273 and D282) are conserved in Map53/73 (V204, R206, C273, G275, R278, R279, V302 and D311; May and May, 1999) . These include four residues that bind zinc and two residues that directly contact DNA (May and May, 1999). Conservation of these amino acids suggests that Map53/73 binds DNA at the canonical p53 DNA-binding sites and that these residues should be analysed for mutations. Mutations have rarely been demonstrated in Hsp73 (Corn et al., 1999) or in Hsp63 (Sunahara et al., 1999) . Mutations in p53 are also rare in non-mammalian organisms, although a point mutation has been identi®ed for Map53/73 (Barker et al., 1997) .
Many SAM-containing variants of Hsp63 and Hsp73 genes result from alternative splicing and do not possess p53-like functions such as oligomerization, activation of promoters containing p53-binding sites and induction of apoptosis (Jost et al., 1997; Kaghad et al., 1997; De Laurenzi et al., 1998; Yang et al., 1998; Thanos and Bowie, 1999; Kaelin, 1999) . Because of the almost complete identity of the core sequences of Map53 and Map73, these gene products may result from alternative splicing and may have variable functions related to the nature and timing of interactions between other proteins and the SAM domain of Map73. This unique feature of Map53 and Map73 proteins provides an excellent opportunity for study of SAM domain functions in general. 
Protein expression
Hsp53 is important in regulating cell cycle and apoptosis and is ubiquitously expressed at low levels in normal tissues (Marin and Kaelin, 2000) . Expression patterns for Hsp73 and Hsp63 are less well characterized, but these proteins are usually restricted to speci®c tissues (Yang et al., 1998; Kaelin, 1999) . Since Hsp53 is widely expressed in human tissues, it is not surprising that the Map53 protein was encountered in all six clam tissues (Figure 3) . Map73 was not detected by this method in normal clam hemocytes, although it might be present at very low levels in adductor muscle from normal clams (Figure 3) . Western blots also revealed a third band of *70 kDa that may be an unidenti®ed p53-related protein or another splice variant of Map53/73 (Figure 3 ).
Map53 and Map73 in clam leukemia
In humans, expression of p53 is depressed in fresh tissues derived from patients with acute myelogenous leukemia (AML) and in myeloproliferative diseases such as chronic myeloid leukemia (CML), myelo®-brosis and polycythemia vera (Prokocimer et al., 1986) . In contrast, expression is often elevated in Burkitt's lymphoma (Prokocimer et al., 1986) .
Although elevated expression of Map53 was not observed in leukemic clam hemocytes, the increase in Map73 expression seen in hemocytes and adductor muscle is consistent with an increase in p73 transcripts and protein in a variety of leukemic cell lines and leukemia patients (Peters et al., 1999) . However, Corn et al. (1999) found that the promoter region of the p73 gene is methylated in Burkitt's lymphoma cells and concluded that p73 is not likely to be expressed in these cancers.
The Map53/73 antibody does not distinguish between the two clam proteins in in situ assays. Immunocytochemistry using this antibody demonstrated that clam p53 family members were localized predominantly within the nucleus in normal clam hemocytes ( Figure  4a ) and exclusively within the cytoplasm of leukemic clam hemocytes (Figure 4b ). Western blot analysis of normal clam hemocytes showed expression of only Map53; Map73 was not detected in normal hemocytes by this method (Figure 3a) . Therefore, it is likely that in normal clam hemocytes, nuclear staining is only from p53 localization (Figure 4a ). In clam leukemia cells, the antibody may simultaneously be demonstrating localization of p53 and p73 in the cytoplasm (Figure 4b ). The clam p53/73 antibody also recognized p53 family members in the nuclei of human AML-M5 cells derived from a patient (Figure 4c ).
The precise mechanisms of involvement of p53 family members in human leukemias, especially Burkitt's lymphoma, are only now being determined. An explanation of our results may be provided by the recently discovered anti-apoptotic activity of mammalian p73 found in the developing neurons of mice (Pozniak et al., 2000) . Relative levels of Map53 and Map73 might determine whether clam leukemia cells proliferate or undergo apoptosis and die.
Finally, the cytoplasmic sequestration, or nuclear exclusion, of p53/p73 proteins in clam leukemia cells re¯ects a similar situation seen in several human cancers (Moll et al., 1992 (Moll et al., , 1996 Schlamp et al., 1997; Nagai et al., 1998; Lu et al., 2000) . A number of mechanisms may be responsible for this phenomenon. It is possible that the nuclear import mechanism mediated by the NLS of Map53/73 is malfunctioning. In mammalian cells, nuclear import normally involves recognition of the NLS by import proteins like importin a (Liang and Clarke, 1999; Kim et al., 2000) and subsequent transport of p53 to the nucleus on microtubules using the molecular motor dynein (Giannakakou et al., 2000) . Alternatively, the nuclear export mechanism mediated by the NES of Map53/73 may be overactive, removing Map53/73 as soon as the proteins enter the nucleus (Giannakakou et al., 2000) . Studies are underway to discriminate between these alternative means for excluding Map53/p73 from the nucleus, using antibodies to dynein for the former and leucomycin B for the latter (Giannakakou et al., 2000) . Regardless of which mechanism is involved, the result would be inhibition of any anti-proliferative activities of Map53/73. Such mechanisms could be very important in understanding this disease in clams, since leukemia cells in clams divide slowly, do not die during the life-time of the diseased clam and accumulate to approximately 600 times the numbers of normal hemocytes (Walker CW, unpublished observations).
Clam leukemia oers signi®cant advantages over currently available models for studying the normal and abnormal functions of p53 family members. The clam model provides an in vitro and in vivo alternative to the relatively few human leukemia cell lines. Also, naturally occurring populations of clams (including leukemic individuals) are more similar to an outbreeding, human clinical population than are those generated from inbred mouse strains or by intentional exposure to known tumor viruses. Currently M. arenaria is already being used to study a gonadal neoplasm (germinoma; Van Beneden et al., 1998) . Further studies of these gene products in clams may reveal p53/p73-related molecular mechanisms that are held in common with Burkitt's lymphoma or other human cancers.
Evolution of p53 homologues p53 family members have been found throughout the vertebrates and in some invertebrates, like mollusks (L. forbesi and M. arenaria) and arthropods (D. melanogaster). The existence and structure of these genes, particularly in invertebrates, suggests that a p53/p63-like gene is ancient and already existed in organisms 550 ± 600 million years ago (Figure 6 ). Both deuterostomes and protostomes have p63/p73-like proteins with a C-terminal SAM domain, suggesting that this may be the ancestral form of the protein. Similarly, the alternatively spliced forms of the p63 and p73 proteins are evolutionary conserved and probably existed in the ancestral gene. Map53 and Map73 share a nearly identical core sequence, diverging at the 3' end. This leads us to believe that Map53 and Map73 may be splice variants of the same gene. We are sequencing genomic DNA to determine the validity of this idea. The Map53/73 core sequence appears to be a mosaic of the corresponding human proteins, with the TAD more like Hsp53 and the DBDs more like Hsp63 and Hsp73. The high sequence conservation suggests that traditional human cell cycle, negative-regulatory, DNA editing and repair and apoptosis genes may be transcriptional targets for clam p53/p73. Since this is the only non-vertebrate organism for which we currently have information on the structure, expression and subcellular localization of both p53 and p73, further studies of the genomic sequence and gene products in the clam may elucidate the function and evolution of this important gene family.
Materials and methods
Cloning and sequencing Map53 and Map73
A cDNA library was constructed in lambda ZAP (Stratagene) using polyA(+)-selected RNA samples from normal clam tissue (visceral mass). Ampli®ed titer of the library was 2.5610
8 PFUs/ml with 84% recombinants. Partial sequence for Map53 was obtained by RT ± PCR using polyA(+)-selected RNA as template and degenerate primers designed after conserved motifs in vertebrate p53 DBD III (VVR/ KRCPHH) and DBD V (EVRVCACP). The Map53 RT ± PCR product was used as a probe to screen the cDNA library. Partial sequences for Map53 (Accessions #45237 and #U45238) were obtained and extended using 5' and 3' RACE PCR (Gibco/BRL) on cDNA from normal clam hemocytes using primers designed to the Map53 sequence. Finally, Map53 and Map73 full-length clones, including 5' and 3' UTRs, were obtained by Marathon RACE PCR (CLON-TECH). Positive RACE PCR products were identi®ed by Southern blot analysis (Sambrook et al., 1989) , cloned into a pCRII vector (Invitrogen) and sequenced in both directions at the University of Maine Automated Sequencing Facility. Contiguous sequences were assembled and primers were designed to amplify the full-length Map53 and Map73 sequences from single-stranded cDNA synthesized from gill RNA of the same individual. The same forward primer (5'-TCATATTTGGTAATATGAGCCACGAG-3') was paired with a reverse primer for either Map53 (5'-CCAACT-CAAATCGTTGTGAAAATGG-3') or Map73 (5'-GTTCAGCGTCAAAAGCAGATTAGTGA-3') to amplify a single band with a high ®delity polymerase (Accutaq LA; Sigma). The full-length PCR products for Map53 and Map73 were cloned and sequenced as above (Accession #AF253323 and #AF253324, respectively) . Nucleotide dierences in the resulting sequences probably re¯ect polymorphisms.
Antibody synthesis
A polyclonal antibody to Map53/73 was raised against a peptide synthesized from a highly immunogenic region including part of DBD V (Map53/73 23-mer CACPGRDR-KADERGSLPPMVSGG). The peptide was synthesized by the Merri®eld solid-phase method on an Applied Biosystems Model 431A peptide synthesizer, using Fast Moc chemistry cycles, conjugated to BSA with gluteraldehyde, and the resulting conjugate was used to immunize three New Zealand White Rabbits (Millbrook Farm, MA, USA; Harlow and Lane, 1999) . Antibodies were anity-puri®ed on an A-Gel column (BioRad). The polyclonal antibody obtained was successfully screened for its ability to recognize both Map53 and Map73 proteins by Western blot analysis of both in vitro expressed clam proteins and whole cell extracts of clam proteins from various tissues (Figure 3 ).
In vitro protein synthesis and Western blots
Six tissues (hemocytes, gill, gonad, digestive gland, mantle and adductor muscle) were dissected from normal and leukemic clams and¯ash frozen in liquid nitrogen. Tissues were homogenized in 30 mM Tris pH 8.0, 3 mM MgCl 2 , 0.5% Trition X-100, 5 mM DTT which contained protease inhibitors (7.4 mg/ml TLCK, 5 mg/ml leupeptin, 7 mg/ml pepstatin A, 16.7 mg/ml aprotinin, 1 mM PMSF). Homogenates were centrifuged at 11 000 g at 48C for 10 min. Concentration of solubilized protein in the supernatants was determined by Bradford assay (Bio-Rad).
Proteins were denatured at 958C for 3 min in loading buer (50 mM Tris-HCl, pH 6.8, 2% SDS and 10% glycerol) with 100 mM dithiothreitol (DTT). Fifty to 75 mg of protein were loaded onto duplicate 10% Tris/glycine SDS ± PAGE gels. After electrophoresis at 20 mA/gel, one gel was stained in Coomassie Brilliant Blue R-250 : methanol : acetic acid (0.1% : 50% : 10%) and destained in methanol : acetic acid (45% : 10%). Gels were then soaked in methanol : acetic Figure 6 Phylogenetic relationship between members of the p53 family. The unrooted, neighbor-joined tree, based on alignment of vertebrate and invertebrate p53, p63 and p73 proteins, suggests that overall the invertebrate p53/p73s have a closer relationship to the p63/p73 proteins than to the p53s. Numbers indicate branches with signi®cant bootstrap values. Five hundred bootstrap replicas were analysed. The scale bar indicates the number of substitutions per site. The p53s from the ®sh superorder Ostariophysi and the unranked group Neoteleostei are indicated. Abbreviations: Bb, Barbus barbus; Bt, Bos taurus; Ca, Chlorocebus aethiops. Cf, Canis familiaris; Cg, Cricetulus griseus; Cp, Cavia porcellus; Dm, Drosophila melanogaster; Dr, Danio reiro; Fc, Felis catus; Gg, Gallus gallus; Hs, Homo sapiens; Ip, Ictalurus punctatus; Ma, mya arenaria; Mm, Mus musculus; Mn, Mastomys natalensis; Oa, Ovis aries; Oc, Oryctolagus cuniculus; Ol, Oryzias latipes; Om, Oncorhynchus mykiss; Pf, Platichthys¯esus; Rn, Rattus norwegicus; Sq, Loligo forbesi; SS, Sus scrofa; Tm, Tetraodon miurus; Xh, Xiphophorus helleri; Xl, Xenopus laevis acid : glycerol (7% : 7% : 1%) for 30 min and dried under a vacuum at 808C for 1 h. The proteins on the duplicate gel were electroblotted at 200 mA for 50 min onto an Immobilon-P membrane (Millipore) using a semi-dry blotting system (Labconco). Membranes were blocked overnight in TTBS (100 mM Tris pH 7.5, 0.9% NaCl, 0.1% Tween 20)+1 mg/ ml gelatin at 48C. After three washes in TTBS, membranes were incubated in a 1 : 150 dilution of Map53/73 antibody for 2 ± 4 h at room temperature. Membranes were washed in TTBS and incubated 45 ± 60 min with a 1 : 10 000 dilution of goat-anti-rabbit IgG secondary antibody conjugated to horseradish peroxidase (Sigma). Membranes were washed in TTBS, equilibrated in 0.1 M Tris-HCl, pH 8.5, then incubated for 1 min in enhanced chemiluminescence (ECL) solution (0.1 M Tris pH 8.5, 0.05% hydrogen peroxide, 680 mM p-coumeric acid and 0.13 mg/ml luminol in DMSO (Sigma)). Membranes were exposed to Hyper®lm MP (Amersham Pharmacia Biotech) for 30 ± 60 s.
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S-radiolabeled and unlabeled Map53 and Map73 proteins were expressed in vitro using the TNT Quick-Coupled Reticulocyte Lysate System (Promega). Two ml of the TNT reactions were subjected to SDS-polyacrylamide gel electrophoresis, followed by autoradiography (data not shown) or Western blot analysis (as described above) to con®rm protein synthesis.
Collection of clam hemocytes and staging clam leukemia
Clams were collected from intertidal sand¯ats on Marsh Island in New Bedford Harbor at Fairhaven, MA, USA. For biopsy, a small aliquot (2 ± 3 ml) of hemolymph was removed from the blood sinus surrounding the heart using a syringe and 21 gauge needle, placed in a¯at-bottom 96-well microtiter plate and incubated for 2 ± 24 h at 88C. Depending upon the microscopic appearance of the hemocytes, clams were classi®ed as normal (no leukemic cells), incipient or intermediate (50 and 4100%) or 100% leukemic. When appropriate, more precise classi®cation of clam hemocytes was accomplished using the murine monoclonal antibody, 1E10, which is speci®c for a transmembrane protein in leukemic hemocytes of M. arenaria and capable of dierentiating one leukemic cell in a ®eld of 100 000 cells (Miosky et al., 1989) .
Immunocytochemistry
Hemocytes from normal clams, 100% leukemic clams and cells from a human AML-M5 patient were prepared as cytospins on poly-L-lysine coated slides (Shandon) in a Shandon Cytofuge3 and air dried. Cells were ®xed and permeabilized by immersion in cold (48C) acetone for 10 min. Endogenous peroxidase activity was quenched by 30 min immersion in 0.3% H 2 O 2 in MeOH at room temperature. In situ detection of Map53/73 was accomplished by overnight incubation (48C) with Map53/73 antibody diluted 1 : 50 in 10 mM NaPO 4 pH 7.5, 0.9% NaCl, 0.1% Triton X-100. To visualize the results, slides were developed with the Vectastain ABC Elite Rabbit IgG kit (Vector Laboratories), mounted in DPX mountant (EMS) and photographed using a Spot digital camera on a Zeiss Axiophot microscope. Control cytospins received identical treatment in the absence of primary antibody.
Cytospins of clam and human leukemia cells and oil red O staining
Ramos RA 1 Burkitt's lymphoma cell line (CRL-1596; ATCC), Burkitt's lymphoma cells from a patient and acute monocytic leukemia cells from a patient (AML-M5) were grown at 378C in RPMI 1640 with 10% fetal calf serum and 1% penicillin-streptomycin (Sigma) and subsequently separated in Ficoll (A Freedman, personal communication) . Approximately 500 ml of cells from these two human sources and also clam leukemia cells were centrifuged at 900 r.p.m. for 8 min in a Shandon Cytofuge3, treated with oil red O to stain oil droplets and counter-stained with hematoxylin (Humason, 1979) . After staining, cells were mounted in DPX mountant (EMS) and photographed using a Spot digital camera on a Zeiss Axiophot microscope.
Amino acid alignment and phylogenetic analysis
Alignment of the predicted protein sequences for Map53 and Map73, Hsp53, Hsp63a and Hsp73a splice variants, L. forbesi p73 and D. melanogaster p53 was accomplished with Clustal W (Thompson et al., 1994) and manually re®ned with the GenDoc program (Nicholas and Nicholas, 1997). The distances between the sequences were calculated and a neighbor-joining tree produced with the Clustal W program. Gap penalty and gap extension penalty was set to 10 and 0.1, respectively. Bootstrap analysis was performed with 500 bootstrap replicas. The phylogenetic tree was made with the TreeView program (Page, 1996) .
